Search Results - "Lindenmayer, J.P."
-
1
Pomaglumetad methionil: No significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo
Published in Schizophrenia research (01-11-2013)“…Abstract This study tested whether treatment with pomaglumetad methionil (LY2140023 monohydrate), a metabotropic glutamate receptor 2/3 agonist compared with…”
Get full text
Journal Article -
2
Transcranial direct-current stimulation in ultra-treatment-resistant schizophrenia
Published in Brain stimulation (01-01-2019)“…Transcranial direct-current stimulation (tDCS), a non-invasive neurostimulation treatment, has been reported in a number of sham-controlled studies to show…”
Get full text
Journal Article -
3
The relationship of cognitive improvement after cognitive remediation with social functioning in patients with schizophrenia and severe cognitive deficits
Published in Schizophrenia research (01-07-2017)“…Abstract Background This study aims to examine the effects of change in neurocognition on functional outcomes and to examine predictors of change in social…”
Get full text
Journal Article -
4
P.3.d.023 Paliperidone palmitate long-acting injectable delays psychotic and mood symptom relapse in schizoaffective disorder
Published in European neuropsychopharmacology (01-10-2014)Get full text
Journal Article -
5
Schizophrenia with Impulsive and Aggressive Behaviors
Published in The Psychiatric clinics of North America (01-12-2009)“…Impulsive and aggressive behaviors are important clinical challenges in the treatment of patients with schizophrenia. They occur both in the acute phase as…”
Get full text
Journal Article -
6
Schizophrenia: Measurements of Psychopathology
Published in The Psychiatric clinics of North America (01-09-2007)“…A key problem in schizophrenia research is how to assess the effects of treatment interventions given the spectrum of schizophrenia symptoms and patients'…”
Get full text
Journal Article -
7
Transcultural differences in suicide attempters: Analysis on a high-risk population of patients with schizophrenia or schizoaffective disorder
Published in Schizophrenia research (01-01-2007)“…Abstract The aim of the study was to investigate transcultural differences between schizophrenia spectrum disorder patients who did or did not attempt suicide…”
Get full text
Journal Article -
8
P.0508 Correlation between patient engagement with a digital medicine system and clinical symptom improvement
Published in European neuropsychopharmacology (01-12-2021)Get full text
Journal Article -
9
The role of adherence to medication in the effectiveness of long-term treatment of schizophrenia
Published in European psychiatry (01-03-2007)Get full text
Journal Article -
10
N-desmethylclozapine: is there evidence for its antipsychotic potential?
Published in Clinical neuropharmacology (01-05-2009)“…N-Desmethylclozapine (NDMC), one of clozapine's major metabolites, has become a recent focus of study for both its antipsychotic and metabolic effects. The aim…”
Get full text
Journal Article -
11
The InterSePT scale for suicidal thinking reliability and validity
Published in Schizophrenia research (01-09-2003)“…Background: The InterSePT Scale for Suicidal Thinking (ISST) is a 12-item instrument for the assessment of current suicidal ideation in patients with…”
Get full text
Journal Article -
12
Pharmacological treatment strategies for schizophrenia
Published in Expert review of neurotherapeutics (01-07-2004)“…The pharmacological choices for the treatment of schizophrenia have been greatly expanded with the availability of the atypical compounds clozapine (Clozaril,…”
Get more information
Journal Article -
13
Tardive dyskinesia, glucose and lipids with conventional and atypical antipsychotics
Published in Schizophrenia research (01-03-2003)Get full text
Journal Article -
14
Validation of a manic-like symptom scale from the positive and negative syndrome scale
Published in European neuropsychopharmacology (01-10-2002)Get full text
Journal Article -
15
Long-acting risperidone microspheres for treatment of patients with schizophrenia
Published in European neuropsychopharmacology (2001)Get full text
Journal Article